Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Antiviral therapy reduced incidence of long COVID-19 ...

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Treatment options are lacking and research remains fragmented. Nevertheless, a pattern is emerging in the understanding of ...

While COVID levels are moderate and respiratory syncytial virus, or RSV, levels are low in Illinois, hospital admissions are ...

CHICAGO -- Pfizer has begun a Phase 2 and 3 clinical trial of its COVID-19 antiviral treatment, Paxlovid, in children ages 6 to 17, the company said Wednesday in a news release. The study will ...

A new study from UCSD and international collaborators reports five promising molecules that could lead to antiviral ...

Ohio faces a surge in COVID-19 hospitalizations as cold and flu season peaks. Learn what symptoms to watch for and how to ...

Koumans and team pointed out that while adults ages 65 and older make up 17.7% of the U.S. population, this group bore a ...